Aaron is a Senior Director at Teva Pharmaceuticals where he collaborates with global, regional, and national trade associations, health authorities, industry peers, and patient advocates to design and implement policies that enable patient access to Teva’s portfolio of biopharmaceutical products. He leads a global trade association task force related to implementing a single global development paradigm for generic and biosimilar medicines and has crafted policies to improve the efficiency, predictability, and transparency of regulatory reviews. Aaron’s prior experience includes 10+ years at FDA where he served as a user fee negotiator and led policy, budget, strategic planning activities. He has also consulted for drug, vaccine, and medical device companies and worked for a Member of Congress.
Speakers